Sana Biotechnology Inc (NASDAQ:SANA) shares, rose in value, with the stock price down by -7.10% to the previous day’s close as strong demand from buyers drove the stock to $8.51.
Actively observing the price movement in the last trading, the stock closed the session at $9.16. The value of beta (5-year monthly) was 1.62. Referring to stock’s 52-week performance, its high was $12.00, and the low was $2.74. On the whole, SANA has fluctuated by -13.25% over the past month.
With the market capitalization of Sana Biotechnology Inc currently standing at about $1.88 billion, investors are eagerly awaiting this quarter’s results, scheduled for May 06, 2024 – May 10, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.32, which is expected to increase to -$0.22 for fiscal year -$1.21 and then to about -$1.37 by fiscal year 2025. Data indicates that the EPS growth is expected to be 14.20% in 2025, while the next year’s EPS growth is forecast to be -13.20%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that SANA’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of SANA currently trading nearly -8.90% and 4.50% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 45.14, while the 7-day volatility ratio is showing 7.58% which for the 30-day chart, stands at 7.76%. Furthermore, Sana Biotechnology Inc (SANA)’s beta value is 1.62, and its average true range (ATR) is 0.75.
A comparison of Sana Biotechnology Inc (SANA) with its peers suggests the former has fared considerably weaker in the market. SANA showed an intraday change of -7.10% in last session, and over the past year, it grew by 164.29%%.
Data on historical trading for Sana Biotechnology Inc (NASDAQ:SANA) indicates that the trading volumes over the past 10 days have averaged 1.33 million and over the past 3 months, they’ve averaged 3.44 million. According to company’s latest data on outstanding shares, there are 197.86 million shares outstanding.
Nearly 46.50% of Sana Biotechnology Inc’s shares belong to company insiders and institutional investors own 40.62% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 24.68 million shares as on Mar 15, 2024, resulting in a short ratio of 9.36. According to the data, the short interest in Sana Biotechnology Inc (SANA) stood at 11.19% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 22.08 million. The stock has risen by 108.58% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SANA stock heading into the next quarter.
